This document is a USPTO patent application (US20260083910A1) for novel methods, systems, and devices related to insulin delivery. The application, filed by inventors Bryan Mazlish and Lane Desborough, describes techniques for selecting basal insulin delivery rates based on projected blood glucose levels and generating specific delivery instructions for insulin devices.

As this is a patent application, it does not impose immediate regulatory requirements or compliance deadlines on regulated entities. However, it signifies potential future technological advancements in diabetes management that may influence the development and regulation of insulin delivery devices and associated software. Companies in the pharmaceutical and medical device sectors should monitor patent filings for insights into emerging technologies and potential intellectual property landscapes.